GSK961081
MAB108115
Phase 1 small_molecule completed
Quick answer
GSK961081 for Pulmonary Disease, Chronic Obstructive is a Phase 1 program (small_molecule) at Theravance Biopharma with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Theravance Biopharma
- Indication
- Pulmonary Disease, Chronic Obstructive
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed